دورية أكاديمية

Genomic Epidemiology Identifies Azole Resistance Due to TR 34 /L98H in European Aspergillus fumigatus Causing COVID-19-Associated Pulmonary Aspergillosis.

التفاصيل البيبلوغرافية
العنوان: Genomic Epidemiology Identifies Azole Resistance Due to TR 34 /L98H in European Aspergillus fumigatus Causing COVID-19-Associated Pulmonary Aspergillosis.
المؤلفون: Simmons, Benjamin C., Rhodes, Johanna, Rogers, Thomas R., Verweij, Paul E., Abdolrasouli, Alireza, Schelenz, Silke, Hemmings, Samuel J., Talento, Alida Fe, Griffin, Auveen, Mansfield, Mary, Sheehan, David, Bosch, Thijs, Fisher, Matthew C.
المصدر: Journal of Fungi; Nov2023, Vol. 9 Issue 11, p1104, 36p
مصطلحات موضوعية: PULMONARY aspergillosis, ASPERGILLUS fumigatus, GENOMICS, VIRUS diseases, EPIDEMIOLOGY, ANTIFUNGAL agents
مستخلص: Aspergillus fumigatus has been found to coinfect patients with severe SARS-CoV-2 virus infection, leading to COVID-19-associated pulmonary aspergillosis (CAPA). The CAPA all-cause mortality rate is approximately 50% and may be complicated by azole resistance. Genomic epidemiology can help shed light on the genetics of A. fumigatus causing CAPA, including the prevalence of resistance-associated alleles. We present a population genomic analysis of 21 CAPA isolates from four European countries with these isolates compared against 240 non-CAPA A. fumigatus isolates from a wider population. Bioinformatic analysis and antifungal susceptibility testing were performed to quantify resistance and identify possible genetically encoded azole-resistant mechanisms. The phylogenetic analysis of the 21 CAPA isolates showed that they were representative of the wider A. fumigatus population with no obvious clustering. The prevalence of phenotypic azole resistance in CAPA was 14.3% (n = 3/21); all three CAPA isolates contained a known resistance-associated cyp51A polymorphism. The relatively high prevalence of azole resistance alleles that we document poses a probable threat to treatment success rates, warranting the enhanced surveillance of A. fumigatus genotypes in these patients. Furthermore, potential changes to antifungal first-line treatment guidelines may be needed to improve patient outcomes when CAPA is suspected. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Fungi is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:2309608X
DOI:10.3390/jof9111104